August 17, 2017

077 — Cancer Immunotherapy

The newest and most promising therapies for challenging cancers are adopting molecular-biology strategies.  Brain tumors are especially problematic because of their location impedes patient function and presents formidable barriers to surgical treatments.  But new molecular approaches show promise.  A series of new techniques from viruses genetically trained to attack the tumor, to genetic modifications of immune cells, to new types of monoclonal antibodies represent a few of the new tricks researchers are now deploying in the fight against these deadly conditions.  Dr. Duane Mitchell is a Professor at the University of Florida.  He is a neurosurgeon that is discovering and refining the leading edge of next generation therapies.  In today’s podcast, he shares his expertise in explaining the new types of technologies and the potential promise they may bring.

Website: Dr. Duane Mitchell and the UF Brain Tumor Immunotherapy Program

Like the podcast?  Please subscribe and write a review!

 Stitcher    iTunes   Player FM   TuneIn

4 Comments on 077 — Cancer Immunotherapy

  1. Glad you went for the colonoscopy. I had 3 polyps first time. You just lengthened your lifespan by a decade or so.

  2. There was a lot of talk about killing cells in tumors. Would these techniques work for non-solid cancers, such as leukemias?

  3. Fortunate timing (for me) on your colonoscopy PSA. I’m 50 and going in for my first colonoscopy this Monday.

    Yes, I was starting to freak out about the prep and gallons of laxative and missed work. You put my mind at ease.

    My grandfather that was born on a small island in Greece during the American Civil War died of colon cancer in the 1940s. My dad died of cancer 28 years ago, but he was one of the guys in the 1950s who had to stand and watch the above-ground nuclear tests in Nevada. Then when they went underground with the tests he assayed and analyzed the soils. In my mind he’s statistical noise in terms of family cancer history.

Leave a Reply

Your email address will not be published.


*